Genetic Basis of Haloperidol Resistance in Is Complex and Dose Dependent

English version České info

Variation in response to a drug can be determined by many factors. In the model organism baker's yeast, many studies of chemical resistance traits have uncovered a complex genetic basis of such resistance. However, an in-depth study of how drug dose alters the effects of underlying genetic factors is lacking. Here, we employed linkage analysis to map the specific genetic loci underlying response to haloperidol, a small molecule therapeutic drug, using a large panel of segregants from a cross between two genetically divergent yeast strains BY (a laboratory strain) and RM (a vineyard strain). We found that loci associated with haloperidol resistance are dose-dependent. We also showed that variants in the oxysterol-binding-protein-like domain of the gene SWH1 underlie the major locus detected at all doses of haloperidol. Genetic interactions among genes SWH1, MKT1, and IRA2 in the RM background contribute to the differential response at high concentrations of haloperidol.

Vyšlo v časopise: Genetic Basis of Haloperidol Resistance in Is Complex and Dose Dependent. PLoS Genet 10(12): e32767. doi:10.1371/journal.pgen.1004894
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004894

Souhrn

Zdroje

1. LitiG, LouisEJ (2012) Advances in Quantitative Trait Analysis in Yeast. Plos Genetics 8: e1002912.

2. BremRB, YvertG, ClintonR, KruglyakL (2002) Genetic dissection of transcriptional regulation in budding yeast. Science 296: 752–755.

3. FayJC, McCulloughHL, SniegowskiPD, EisenMB (2004) Population genetic variation in gene expression is associated with phenotypic variation in Saccharomyces cerevisiae. Genome Biology 5: R26.

4. PicottiP, Clement-ZizaM, LamH, CampbellDS, SchmidtA, et al. (2013) A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis. Nature 494: 266–270.

5. SteinmetzLM, SinhaH, RichardsDR, SpiegelmanJI, OefnerPJ, et al. (2002) Dissecting the architecture of a quantitative trait locus in yeast. Nature 416: 326–330.

6. SinhaH, DavidL, PasconRC, Clauder-MunsterS, KrishnakumarS, et al. (2008) Sequential elimination of major-effect contributors identifies additional quantitative trait loci conditioning high-temperature growth in yeast. Genetics 180: 1661–1670.

7. Cubillos FA, Parts L, Salinas F, Bergstrom A, Scovacricchi E, et al.. (2013) High-Resolution Mapping of Complex Traits with a Four-Parent Advanced Intercross Yeast Population. Genetics 195: 1141-+.

8. YangYD, Foulquie-MorenoMR, ClementL, ErdeiE, AnTH, et al. (2013) QTL Analysis of High Thermotolerance with Superior and Downgraded Parental Yeast Strains Reveals New Minor QTLs and Converges on Novel Causative Alleles Involved in RNA Processing. Plos Genetics 9: e1003693.

9. DemoginesA, SmithE, KruglyakL, AlaniE (2008) Identification and dissection of a complex DNA repair sensitivity phenotype in Baker's yeast. PLoS Genet 4: e1000123.

10. GerkeJ, LorenzK, CohenB (2009) Genetic interactions between transcription factors cause natural variation in yeast. Science 323: 498–501.

11. LorenzK, CohenBA (2012) Small- and large-effect quantitative trait locus interactions underlie variation in yeast sporulation efficiency. Genetics 192: 1123–1132.

12. DeutschbauerAM, DavisRW (2005) Quantitative trait loci mapped to single-nucleotide resolution in yeast. Nature Genetics 37: 1333–1340.

13. PerlsteinEO, RuderferDM, RobertsDC, SchreiberSL, KruglyakL (2007) Genetic basis of individual differences in the response to small-molecule drugs in yeast. Nat Genet 39: 496–502.

14. EhrenreichIM, TorabiN, JiaY, KentJ, MartisS, et al. (2010) Dissection of genetically complex traits with extremely large pools of yeast segregants. Nature 464: 1039–1042.

15. BloomJS, EhrenreichIM, LooWT, LiteTL, KruglyakL (2013) Finding the sources of missing heritability in a yeast cross. Nature 494: 234–237.

16. SumiyoshiT, KidoH, SakamotoH, UrasakiK, SuzukiK, et al. (1994) In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol. Pharmacol Biochem Behav 47: 553–557.

17. EricsonE, GebbiaM, HeislerLE, WildenhainJ, TyersM, et al. (2008) Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS Genet 4: e1000151.

18. RaineyMM, KorostyshevskyD, LeeS, PerlsteinEO (2010) The antidepressant sertraline targets intracellular vesiculogenic membranes in yeast. Genetics 185: 1221–1233.

19. HalliwellWH (1997) Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol 25: 53–60.

20. ChenJ, KorostyshevskyD, LeeS, PerlsteinEO (2012) Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy. PLoS One 7: e34024.

21. CaseyDR, SebaiSC, ShearmanGC, CesO, LawRV, et al. (2008) Formulation affects the rate of membrane degradation catalyzed by cationic amphiphilic drugs. Industrial & Engineering Chemistry Research 47: 650–655.

22. LumPY, ArmourCD, StepaniantsSB, CavetG, WolfMK, et al. (2004) Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116: 121–137.

23. MoebiusFF, BermoserK, ReiterRJ, HannerM, GlossmannH (1996) Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. Biochemistry 35: 16871–16878.

24. Jones EW, Pringle JR, Broach JR (1992) The Molecular and Cellular Biology of the Yeast Saccharomyces: Cold Spring Harbor Laboratory Press.

25. ZweytickD, HrastnikC, KohlweinSD, DaumG (2000) Biochemical characterization and subcellular localization of the sterol C-24(28) reductase, erg4p, from the yeast saccharomyces cerevisiae. FEBS Lett 470: 83–87.

26. OlcerM, HakyemezG (1988) Investigations of Some Physicochemical Properties of Haloperidol Which May Affect Its Activity. Journal of Clinical Pharmacy and Therapeutics 13: 341–349.

27. BantaLM, RobinsonJS, KlionskyDJ, EmrSD (1988) Organelle assembly in yeast: characterization of yeast mutants defective in vacuolar biogenesis and protein sorting. J Cell Biol 107: 1369–1383.

28. BremRB, KruglyakL (2005) The landscape of genetic complexity across 5,700 gene expression traits in yeast. Proceedings of the National Academy of Sciences of the United States of America 102: 1572–1577.

29. SchmalixWA, BandlowW (1994) SWH1 from yeast encodes a candidate nuclear factor containing ankyrin repeats and showing homology to mammalian oxysterol-binding protein. Biochim Biophys Acta 1219: 205–210.

30. TaylorFR, SaucierSE, ShownEP, ParishEJ, KandutschAA (1984) Correlation between Oxysterol Binding to a Cytosolic Binding-Protein and Potency in the Repression of Hydroxymethylglutaryl Coenzyme-a Reductase. Journal of Biological Chemistry 259: 2382–2387.

31. DawsonPA, VanderwesthuyzenDR, GoldsteinJL, BrownMS (1989) Purification of Oxysterol Binding-Protein from Hamster Liver Cytosol. Journal of Biological Chemistry 264: 9046–9052.

32. ImYJ, RaychaudhuriS, PrinzWA, HurleyJH (2005) Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature 437: 154–158.

33. BreunigJS, HackettSR, RabinowitzJD, KruglyakL (2014) Genetic basis of metabolome variation in yeast. PLoS Genet 10: e1004142.

34. SmithEN, KruglyakL (2008) Gene-environment interaction in yeast gene expression. PLoS Biol 6: e83.

35. TanakaK, LinBK, WoodDR, TamanoiF (1991) Ira2, an Upstream Negative Regulator of Ras in Yeast, Is a Ras Gtpase-Activating Protein. Proceedings of the National Academy of Sciences of the United States of America 88: 468–472.

36. TanakaK, NakafukuM, TamanoiF, KaziroY, MatsumotoK, et al. (1990) Ira2, a 2nd Gene of Saccharomyces-Cerevisiae That Encodes a Protein with a Domain Homologous to Mammalian Ras Gtpase-Activating Protein. Molecular and Cellular Biology 10: 4303–4313.

37. BroachJR (1991) Ras Genes in Saccharomyces-Cerevisiae - Signal Transduction in Search of a Pathway. Trends in Genetics 7: 28–33.

38. EhrenreichIM, BloomJ, TorabiN, WangX, JiaY, et al. (2012) Genetic architecture of highly complex chemical resistance traits across four yeast strains. PLoS Genet 8: e1002570.

39. TadauchiT, InadaT, MatsumotoK, IrieK (2004) Posttranscriptional regulation of HO expression by the Mkt1-Pbp1 complex. Mol Cell Biol 24: 3670–3681.

40. TkachJM, YimitA, LeeAY, RiffleM, CostanzoM, et al. (2012) Dissecting DNA damage response pathways by analysing protein localization and abundance changes during DNA replication stress. Nature Cell Biology 14: 966–976.

41. DimitrovLN, BremRB, KruglyakL, GottschlingDE (2009) Polymorphisms in multiple genes contribute to the spontaneous mitochondrial genome instability of Saccharomyces cerevisiae S288C strains. Genetics 183: 365–383.

42. LevineTP, MunroS (2001) Dual targeting of Osh1p, a yeast homologue of oxysterol-binding protein, to both the Golgi and the nucleus-vacuole junction. Molecular Biology of the Cell 12: 1633–1644.

43. KvamE, GoldfarbDS (2004) Nvj1p is the outer-nuclear-membrane receptor for oxysterol-binding protein homolog Osh1p in Saccharomyces cerevisiae. Journal of Cell Science 117: 4959–4968.

44. BehCT, CoolL, PhillipsJ, RineJ (2001) Overlapping functions of the yeast oxysterol-binding protein homologues. Genetics 157: 1117–1140.

45. FossEJ, RadulovicD, ShafferSA, GoodlettDR, KruglyakL, et al. (2011) Genetic Variation Shapes Protein Networks Mainly through Non-transcriptional Mechanisms. Plos Biology 9: e1001144.

46. KhanZ, BloomJS, GarciaBA, SinghM, KruglyakL (2009) Protein quantification across hundreds of experimental conditions. Proceedings of the National Academy of Sciences of the United States of America 106: 15544–15548.

47. AlbertFW, TreuschS, ShockleyAH, BloomJS, KruglyakL (2014) Genetics of single-cell protein abundance variation in large yeast populations. Nature 506: 494–497.

48. Dykens JA, Will Y (2008) Drug-induced mitochondrial dysfunction. Hoboken, NJ: John Wiley & Sons xvii, 616 p., 612 p., of plates p

49. Boy-MarcotteE, PerrotM, BussereauF, BoucherieH, JacquetM (1998) Msn2p and Msn4p control a large number of genes induced at the diauxic transition which are repressed by cyclic AMP in Saccharomyces cerevisiae. Journal of Bacteriology 180: 1044–1052.

50. SchmittAP, McEnteeK (1996) Msn2p, a zinc finger DNA-binding protein, is the transcriptional activator of the multistress response in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America 93: 5777–5782.

51. GoldsteinDB (1984) The effects of drugs on membrane fluidity. Annu Rev Pharmacol Toxicol 24: 43–64.

52. StoriciF, LewisLK, ResnickMA (2001) In vivo site-directed mutagenesis using oligonucleotides. Nat Biotechnol 19: 773–776.

53. Burke D, Dawson D, Stearns T (2000) Methods in Yeast Genetics: A Cold Spring Harbor Laboratory Course Manual: CSHL Press.

54. MoranoKA, KlionskyDJ (1994) Differential effects of compartment deacidification on the targeting of membrane and soluble proteins to the vacuole in yeast. J Cell Sci 107 (Pt 10): 2813–2824.

55. VidaTA, EmrSD (1995) A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol 128: 779–792.

56. SilvermanSJ, PettiAA, SlavovN, ParsonsL, BriehofR, et al. (2010) Metabolic cycling in single yeast cells from unsynchronized steady-state populations limited on glucose or phosphate. Proc Natl Acad Sci U S A 107: 6946–6951.